Advances in the application of 3D tumor models in precision oncology and drug screening

Traditional tumor models cannot perfectly simulate the real state of tumors in vivo, resulting in the termination of many clinical trials. 3D tumor models' technology provides new in vitro models that bridge the gap between in vitro and in vivo findings, and organoids maintain the properties of the original tissue over a long period of culture, which enables extensive research in this area. In addition, they can be used as a substitute for animal and in vitro models, and organoids can be established from patients' normal and malignant tissues, with unique advantages in clinical drug development and in guiding individualized therapies. 3D tumor models also provide a promising platform for high-throughput research, drug and toxicity testing, disease modeling, and regenerative medicine. This report summarizes the 3D tumor model, including evidence regarding the 3D tumor cell culture model, 3D tumor slice model, and organoid culture model. In addition, it provides evidence regarding the application of 3D tumor organoid models in precision oncology and drug screening. The aim of this report is to elucidate the value of 3D tumor models in cancer research and provide a preclinical reference for the precise treatment of cancer patients.

Automated summary

Traditional tumor models are unable to accurately simulate the real state of tumors in vivo, leading to the termination of many clinical trials. However, 3D tumor models' technology offers new in vitro models that bridge the gap between in vitro and in vivo findings. Organoids, in particular, can maintain the properties of the original tissue over a long period of culture, enabling extensive research and serving as potential substitutes for animal and in vitro models. 3D tumor models also provide a promising platform for high-throughput research, drug testing, disease modeling, and regenerative medicine.